315 related articles for article (PubMed ID: 19137016)
1. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
[TBL] [Abstract][Full Text] [Related]
2. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
3. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Mungamuri SK; Yang X; Thor AD; Somasundaram K
Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol 3-kinase/Akt pathway negatively regulates Nod2-mediated NF-kappaB pathway.
Zhao L; Lee JY; Hwang DH
Biochem Pharmacol; 2008 Apr; 75(7):1515-25. PubMed ID: 18243161
[TBL] [Abstract][Full Text] [Related]
5. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
[TBL] [Abstract][Full Text] [Related]
6. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
Bibollet-Bahena O; Almazan G
J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
[TBL] [Abstract][Full Text] [Related]
7. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
[TBL] [Abstract][Full Text] [Related]
9. Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.
Martelli AM; Evangelisti C; Chiarini F; Grimaldi C; Manzoli L; McCubrey JA
Expert Opin Investig Drugs; 2009 Sep; 18(9):1333-49. PubMed ID: 19678801
[TBL] [Abstract][Full Text] [Related]
10. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
[TBL] [Abstract][Full Text] [Related]
11. Targeting mTOR signaling in lung cancer.
Marinov M; Fischer B; Arcaro A
Crit Rev Oncol Hematol; 2007 Aug; 63(2):172-82. PubMed ID: 17540577
[TBL] [Abstract][Full Text] [Related]
12. Alpha-chaconine-reduced metastasis involves a PI3K/Akt signaling pathway with downregulation of NF-kappaB in human lung adenocarcinoma A549 cells.
Shih YW; Chen PS; Wu CH; Jeng YF; Wang CJ
J Agric Food Chem; 2007 Dec; 55(26):11035-43. PubMed ID: 18044836
[TBL] [Abstract][Full Text] [Related]
13. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
14. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
Dogra C; Changotra H; Wergedal JE; Kumar A
J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
Agouni A; Sourbier C; Danilin S; Rothhut S; Lindner V; Jacqmin D; Helwig JJ; Lang H; Massfelder T
Carcinogenesis; 2007 Sep; 28(9):1893-901. PubMed ID: 17468516
[TBL] [Abstract][Full Text] [Related]
18. From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy.
Georgakis GV; Younes A
Expert Rev Anticancer Ther; 2006 Jan; 6(1):131-40. PubMed ID: 16375650
[TBL] [Abstract][Full Text] [Related]
19. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells.
Méndez-Samperio P; Pérez A; Rivera L
Cell Immunol; 2009; 256(1-2):12-8. PubMed ID: 19181310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]